EQS-Adhoc: NORMA Group SE (ISIN: DE000A1H8BV3): Non-cash effective goodwill impairment in the EMEA region as of September 30th 2025 in the amount of around EUR 50 million

Maintal, October 27^th 2025 In the course of the preparation of the Interim Statement for the third quarter 2025 of NORMA Group SE (ISIN: DE000A1H8BV3) a non-cash effective goodwill impairment charge totalling around EUR 50 million was identified for the EMEA region as a result of a mandatory impairment test. The impairment requirement is mainly attributable to revised revenue assumptions in the EMEA region for the coming financial years. The impairment requirement will have a corresponding impact on consolidated earnings after taxes, but will not lead to a cash outflow.

The company guidance on the fiscal year 2025 Group Sales and adjusted EBIT-margin* is not affected by the impairment and remains unchanged.

The work on the final accounts is still ongoing. The Interim Statement for the third quarter 2025 will be published on November 4^th.

____________________________
* NORMA Group adjusts certain expenses for the operational management of the company. Details of the adjustments can be found on page 80 of the 2024 annual report.

Contact:
Sebastian Lehmann
VP Investor Relations & Corporate Social Responsibility
E-mail: Sebastian.Lehmann@normagroup.com
Phone: +49 (0)6181 – 6102 741